Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instrument, Reagent, Consumables), Technology (qPCR, dPCR), Application (Oncology, Pathogen Detection, Research, Forensic), End User (Pharma, Academic, Hospitals, CRO) - Forecast to 2024

  • Report ID:MRHC - 104266
  • Pages: 121
  • Apr 2019
  • Formats*: PDF
  • Category: Healthcare

1 Introduction
   1.1 Market Ecosystem
   1.2 Definition
   1.3 Years Considered in study
   1.4 Currency And Limitations
   1.5 Market Buzz and Foregrounds

2 Research Methodology
   2.1 Secondary Research
   2.2 Primary Research
   2.3 Market Analytics

3 Executive Summary

4 Market Insights
   4.1 Drivers
         4.1.1 Increasing incidences and prevalence of genetic and infectious diseases
         4.1.2 Technological advancement in PCR
         4.1.3 Rising number of CROs, forensic, and other research laboratories
   4.2 Restraint
         4.2.1 Technical limitations associated with PCR
         4.2.2 High cost of PCR devices
   4.3 Opportunities
         4.3.1 Emerging opportunities from Asian countries
         4.3.2 Transition from plant to genome based drug discovery
   4.4 Challenges
         4.4.1 Lack of accuracy & standardization in protocol

5 Global Digital PCR and Real-time PCR (qPCR) Market, by Product
   5.1 Introduction
   5.2 Instruments
   5.3 Reagents & Kits
   5.4 Consumables
         5.4.1 Tubes
         5.4.2 Plates
         5.4.3 Caps & Seals
         5.4.4 Others (pressure pads, racks, tray)
   5.5 Software and Services

6 Global Digital PCR and Real-time PCR (qPCR) Market, by Technology
   6.1 Introduction
   6.2 Real Time PCR
   6.3 Digital PCR
         6.3.1 Droplet Digital PCR
         6.3.2 BEAMing Digital PCR

7 Global Digital PCR and Real-time PCR (qPCR) Market, by Application
   7.1 Introduction
   7.2 Clinical
         7.2.1 Pathogen Testing
         7.2.2 Oncology
         7.2.3 Prenatal Screening
         7.2.4 Others
   7.3 Research
         7.3.1 Genetic Variation Analysis
         7.3.2 Protein Analysis
         7.3.3 miRNA and Non-Coding RNA Analysis
   7.4 Forensic

8 Global Digital PCR and Real-time PCR (qPCR) Market, by End User
   8.1 Introduction
   8.2 Pharmaceutical & Biotechnology Companies
   8.3 Hospitals and Diagnostic Labs
   8.4 Academic and Research Laboratories
   8.5 Clinical Research Organizations (CROs)
   8.6 Forensic Laboratories

9 Global Digital PCR and Real-time PCR (qPCR) Market, by Geography
   9.1 Introduction 
   9.2 North America 
         9.2.1 U.S.
         9.2.2 Canada
   9.3 Europe 
         9.3.1 Germany
         9.3.2 France
         9.3.3 U.K.
         9.3.4 Italy
         9.3.5 Spain
         9.3.9 RoE
   9.4 Asia-Pacific
         9.4.1 Japan
         9.4.2 China
         9.4.3 India
         9.4.4 RoAPAC
   9.5 Rest of World
         9.5.1 Latin America
         9.5.2 Middle East & Africa

10 Competitive Landscape
     10.1 Digital PCR Market Share Analysis
     10.2 Real-Tim PCR (qPCR) Market Share Analysis

11 Company Profiles
     11.1 Thermo Fisher Scientific, Inc.
     11.2 F. Hoffmann-La Roche Ltd.
     11.3 Bio-Rad Laboratories
     11.4 QIAGEN N.V.
     11.5 Agilent Technologies
     11.6 bioMérieux S.A.
     11.7 Danaher Corporation
     11.8 Fluidigm Corporation
     11.9 Takara Bio, Inc.
     11.10 Abbott Laboratories
     11.11 Merck KGaA
     11.12 Becton, Dickinson and Company 
     11.13 Promega Corporation
     11.14 Meridian Bioscience, Inc.
     11.15 Analytik Jena AG

12 Appendix
     12.1 Questionnaire

Real Time PCR and digital PCR are used for specific detection and quantification of nucleic acids. The adoption of these techniques helps to measure minor variants within the genetic material. Though, real time PCR is well established technique, digital PCR delivers an absolute measure of target nucleic acid molecules. Factors such as increasing incidence & prevalence of genetic & infectious diseases; technological advancement in PCR; and rising number of CRO, forensic, and other research laboratories are driving the growth in dPCR and qPCR market. Moreover, emerging opportunities from Asian countries and transition from plant to genome based drug discovery will provide high opportunities for this market in forecast period. On the other hand, technical limitations associated with PCR and high cost of PCR devices are expected to restrict the growth of this market.

Potential of Real Time PCR and Digital PCR Market                            

Recently, increasing number of viral diseases put pressure on healthcare sector. For instance, according to the Centers for Disease Control and Prevention (CDC) predictions, there were only 2 Powassan virus neuroinvasive disease cases reported for the year 2008 which has increased to 33 in 2017 in the U.S. Thus, to discover the drug or biomarker for these viral diseases, researchers are widely adopting digital PCR technique. Similarly, advancement in digital PCR techniques holds great promise in detection of rare cancer biomarkers. For instance, researchers are expected to use digital droplet PCR (ddPCR) along with molecular biology techniques to discover new cancer biomarkers. Thus, such a growing advancement and rising prevalence of diseases provide huge potential for adoption of PCR techniques.

Detailed Potential Market Analysis

The dPCR and qPCR market is segmented by product (instruments, reagents & kits, consumables, and software & services), technology (qPCR, dPCR), application (clinical, research, and forensic), end user (pharmaceutical & biotechnology companies, hospitals and diagnostic labs, academic and research laboratories, clinical research organizations (CROs), and forensic laboratories) and geography.

Based on product, reagents and kits accounted for the largest share of dPCR and qPCR market in 2018 due to their repeated usage and rising procurement for various clinical, research, and other applications.

Based on technology, real time PCR commanded the largest share of dPCR and qPCR market in 2018. This is mainly due to increased adoption of qPCR over traditional PCR technology owing to its advantages such as fast start-up time, better temperature control, and real-time measurement. However, dPCR is expected to grow at a fastest CAGR within the forecast year due to growing preference for this technology in clinical research and drug development with absolute detection and reduced consumption of reagents.

On the basis of geographical analysis, North America including U.S. and Canada are anticipated to be the largest market due to increasing funding for qPCR and dPCR technologies, growing incidence & prevalence of infectious and genetic diseases, continuous reduction in gene sequencing cost, and presence of key players in the region. However, Asia Pacific region is expected to grow at a fastest CAGR due to rapidly developing economies, growing aging population coupled with rising incidence of genetic diseases, rise in government support for life science research, growing research & clinical trial outsourcing from the region, and increasing number of CROs.

Key Players dPCR & qPCR players

Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories Inc. (U.S.), QIAGEN N.V. (Netherlands), Takara Bio Inc. (Japan), bioMérieux S.A. (France), Agilent Technologies, Inc. (U.S.), Fluidigm Corporation (U.S.), Abbott Laboratories (U.S.), Merck KGaA (Germany), Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.), Promega Corporation (U.S.), Meridian Bioscience, Inc. (U.S.), and Analytik Jena AG (Germany) are some of the key players in this market. The report provides the information on dPCR market share & qPCR market share of the all key players operating in this market

Report Name
Full Name
Email
Job Title
Company
Country
Phone Number
--
Your Specific Interest
Captcha
This website is secure and we do not share your personal information with any third party. Privacy Policy
Tags: Healthcare Analytical Instrumentation Medical Technologies
Download Free Sample